The Warfield Family Makes a Difference
The Warfields believe that because of STAR’s work over the past decade, the next decade will be brighter for their family and many others! Join them and make the CMTA your cause!Read more ...
The 2018 CMTA Report 35th Anniversary Edition
This year the CMTA is celebrating its 35th anniversary. In this special edition of The CMTA Report, go back in time with us and learn about some of the milestones that have shaped the CMTA. ...Read more ...
A Guide to Physical and Occupational Therapy for CMT
This first-of-its-kind publication outlines the assessment and care of people with CMT. Based on research, experience and patient input, it will help ensure you get the best possible care for your specific needs.Read more ...
Three Major Patient Advocacy Groups Focused on CMT Research Collaborating on FDA “Voice of the Patient” Report
This CMT Awareness Month, the Charcot-Marie-Tooth Association (CMTA) is proud to join the Muscular Dystrophy Association (MDA) as a sponsor of the Hereditary Neuropathy Foundation (HNF) who will be hosting the Externally-led Patient-Focused Drug Development ...Read more ...
Regenacy Pharmaceuticals Announces Collaboration with the CMTA to Advance Ricolinostat for the Treatment of Hereditary Neuropathy
Regenacy Pharmaceuticals, LLC, a clinical-stage biopharmaceutical company, announced a collaboration with the CMTA to validate the role of HDAC6 in multiple forms of CMT disease and evaluate the efficacy of ricolinostat, a selective HDAC6 inhibitor.Read more ...